United States· US:49591-532_59d63ee0-9e77-824d-e063-6394a90ae055
Cytogam
A medicinal product containing human cytomegalovirus immune globulin, registered in United States by Kamada Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
- Manufacturer
- Kamada Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1149591-532-51
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Human cytomegalovirus immune globulin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f64bec2a-636d-4566-b7b7-a0e1dcf405af GET /v1/drugs/f64bec2a-636d-4566-b7b7-a0e1dcf405af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "2500",
"substance": "HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN",
"productndc": "49591-532",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "mg/50mL",
"application_number": "BLA103189",
"marketing_category": "BLA"
}See everything about human cytomegalovirus immune globulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.